Therefore, it is necessary to comprehensively understand the expression of PD‐L1 and TILs in the tumor immune microenvironment of ESCC and their interdependence to explore more reliable prognostic immune factors to predict the prognosis of patients with ESCC. This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.